Theralase Technologies Inc. V.TLT

Valuation

[Camphikefish]

Hello everyone, been here reading most every post for at least 6 years and it feels like I know most of you even having never posted until now. Honestly, there are a lot of super sharp minds on this board and it can be intimidating to join in but here I am! For those of you who may have put a pencil to this, if we secure fda fast track and say we come in with a 60-70% CR from phase 2 with our NMIBC trial, what are we worth on the low side? I know there are other indications and then there's the Covid-19 opportunity ( which by the way, why have we not heard anything more about this ? ) but speaking strictly of NMIBC , what would we be valued at for a buyout ? And how realistic is a buyout and how soon ? I'm sure everyone's laughing at the newbie by now ! So many questions that everyone here wants the answers to ! Just throwing it out there . I could use the money one of these years . Thank you one and all and I promise no politics from this North Carolina medical device sales rep .

[Rumpl3StiltSkin]

$2 US    ;-)

[gojotv!]

Two dollars??! Wow, this Rumplestiltskin is turning gold into straw. Must have read the story backwards. I have no intention of selling under $50/share, FYI. I'm the Charlton Heston of share ownership. Try my cold, dead hands... just try 'em.

[VerusSemperSors]

The Theralase website has a presentation where they size the market opportunity. They calculate: 240,000 (New Bladder Cancer Cases/year in US, Canada & Europe) x 70% (NMIBC) x 30% (BCG Unresponsive) x 1/2 (half the potential market?) x $50,000 (Based on "willingness to pay" of $50-150,000) = $1.1 billion (my caclulator says $1.26 billion)

[99942Apophis]

VerusSemperSors wrote The Theralase website has a presentation where they size the market opportunity. They calculate: 240,000 (New Bladder Cancer Cases/year in US, Canada & Europe) x 70% (NMIBC) x 30% (BCG Unresponsive) x 1/2 (half the potential market?) x $50,000 (Based on "willingness to pay" of $50-150,000) = $1.1 billion (my caclulator says $1.26 billion) Looking at the new&

[CancerSlayer]

  Agree....we would'nt likely capture "half" the market, but I'd still consider capturing 10% of a $2+ Billion market a promising success, especially as it relates to a relatively novel & less used/familiar form of anti-cancer tech. Such a smaller market would still demand a minimum $5 to $10 per share price tag imo, especially considering this tech's

[2b7f6fab]

I say monetize that NMIBC puppy and use the funds to go after the big cancer indications like lung, breast, etc.